Multidrug-Resistant Tuberculosis: Meeting the Challenge
- 15 May 1994
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 29 (5) , 85-96
- https://doi.org/10.1080/21548331.1994.11443021
Abstract
Both public and private institutions are mobilizing to combat drug-resistant TB—indeed, to eliminate all TB. Meeting this goal will require a three-pronged approach: 1) prophylactic isoniazid treatment of latent TB, 2) multidrug (at least six agents in some cases) treatment of active TB to eradicate resistant strains, and 3) correction of the social conditions that have contributed to the current epidemic.Keywords
This publication has 9 references indexed in Scilit:
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient AdherenceAmerican Review of Respiratory Disease, 1993
- Fear, embarrassment, and relief: the tuberculosis epidemic and public health.American Journal of Public Health, 1993
- Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV InfectionNew England Journal of Medicine, 1993
- A Leap of FaithAnnals of Internal Medicine, 1992
- Isoniazid Preventive Therapy for Tuberculosis: Decision Analysis Considering Ethnicity and GenderAmerican Review of Respiratory Disease, 1991
- Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control ProgramsAmerican Review of Respiratory Disease, 1991
- Isoniazid as Preventive Therapy in HIV-Infected Intravenous Drug AbusersPublished by American Medical Association (AMA) ,1991
- Occupational Tuberculous Infections among Pulmonary Physicians in TrainingAmerican Review of Respiratory Disease, 1990